Loading clinical trials...
Loading clinical trials...
Observational - Prognostic Value of p53 and/or p16 Alterations in Ewing Sarcoma
Conditions
Interventions
laboratory biomarker analysis
Locations
1
United States
Children's Oncology Group
Monrovia, California, United States
Start Date
September 1, 2008
Primary Completion Date
May 1, 2016
Completion Date
May 1, 2016
Last Updated
May 17, 2016
NCT01825902
NCT00048984
Lead Sponsor
Children's Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions